Checkpoint Therapeutics I... (CKPT)
NASDAQ: CKPT
· Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM
Checkpoint Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.21M | -28.9M | -9.72M | -6.67M | -10.95M | -19.13M | -5.72M | -16.52M | -10.47M | -21.02M | -10.61M | -14.14M | -16.85M | -29.76M | -11.27M | -9.14M | -6.5M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.96M | 11.76M | 1.61M | 567K | 709K | 672K | 689K | 567K | 969K | 639K | 781K | 729K | 775K | 818K | 779K | 766K | 774K |
Other Working Capital | n/a | 840K | 185K | -741K | -284K | -35K | 471K | 129K | -2.17M | 3.19M | 84K | 3.53M | -437K | -6.01M | 3.98M | 2.42M | 427K |
Other Non-Cash Items | n/a | 7.99M | -471K | 604K | -2.54M | 12.52M | -1.72M | 759K | -7.41M | 6.51M | 26K | 17K | 196K | 6.71M | 39K | 253K | 634K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 1.97M | -2.63M | -741K | 3.37M | -901K | -8M | 3.22M | 2.88M | -1.43M | -1.61M | 2.17M | -3.73M | 12.76M | 3.98M | 2.42M | 440K |
Operating Cash Flow | -11.69M | -7.18M | -11.21M | -6.24M | -6.47M | -6.83M | -14.75M | -11.98M | -14.03M | -15.3M | -11.42M | -11.23M | -19.61M | -9.48M | -6.46M | -5.71M | -4.66M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.69M | n/a | n/a | -1.7M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 38.12M | 9.08M | -1.04M | -50K | -1.21M | 9.99M | -899K | -1.57M | -691K | -2.48M | -21K | -59K | -164K | -82K | -31K | -246K | -651K |
Financial Cash Flow | 38.12M | 9.08M | 10.96M | -50K | 12.79M | 9.99M | 9.1M | 14.55M | 6.81M | 6.89M | 1.01M | 642K | 6.35M | 4.01M | 1.54M | 10.8M | 23.92M |
Net Cash Flow | 26.44M | 1.9M | -248K | -6.29M | 6.31M | 3.16M | -5.65M | 2.58M | -7.22M | -8.41M | -10.41M | -10.59M | -13.26M | -5.47M | -4.92M | 5.09M | 19.26M |
Free Cash Flow | -11.69M | -7.18M | -11.21M | -6.24M | -6.47M | -6.83M | -14.75M | -11.98M | -14.03M | -15.3M | -11.42M | -11.23M | -19.61M | -9.48M | -6.46M | -5.71M | -4.66M |